# Efficacy and Safety of Sinusitis Hevert SL Tablets Compared to Placebo in Adult Patients With Acute, Uncomplicated Rhinosinusitis

> **NCT02296814** · PHASE4 · COMPLETED · sponsor: **Hevert-Arzneimittel GmbH & Co. KG** · enrollment: 314 (actual)

## Conditions studied

- Acute Rhinosinusitis

## Interventions

- **DRUG:** Sinusitis Hevert SL Tablet
- **DRUG:** Placebo for Sinusitis Hevert SL Tablet

## Key facts

- **NCT ID:** NCT02296814
- **Lead sponsor:** Hevert-Arzneimittel GmbH & Co. KG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 314 (ACTUAL)
- **Last updated:** 2015-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02296814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02296814, "Efficacy and Safety of Sinusitis Hevert SL Tablets Compared to Placebo in Adult Patients With Acute, Uncomplicated Rhinosinusitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02296814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*